Skip to main content
logo
NeoRich BioPharma Tech Co., Limited (NRBP)
OTCMKTS · Delayed Price · Currency is USD
0.3701
-0.5293 (-58.85%)
At close: Sep 21, 2026

NeoRich BioPharma Tech Financials Overview

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Revenue
000---
Revenue Growth
-29.10%13.74%----
Gross Profit
000---
Operating Income
-0.23-0.25-0.47-1.07-0.75-0.49
Net Income
-0.23-1-0.57-0.88-4.53-2.44
Earnings Per Share
-0.68-3.05-2.44-4.34-30.86-59.41
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Cash & Investments
0000.010.030.01
Total Debt
0.350.360.370.340.270.71
Net Cash (Debt)
-0.35-0.36-0.37-0.33-0.24-0.7
Net Cash Growth
------
Net Cash Per Share
-1.06-1.08-1.59-1.64-1.67-17.12

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Operating Cash Flow
-0.03-0.03-0.07-0.43-0.21-0.61
Capital Expenditures
------
Free Cash Flow
-0.03-0.03-0.07-0.43-0.21-0.61
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Gross Margin
44.90%50.91%31.02%---
Operating Margin
-7807.69%-7278.06%-15810.84%---
Pretax Margin
-7538.04%-29455.54%-18972.62%---
Profit Margin
-7536.88%-29454.52%-18971.82%---
FCF Margin
-1098.63%-823.64%-2462.91%---

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '26 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
PS Ratio
42.62817.39133.90---